MAPP BIOPHARMACEUTICAL, INC.
Federal contractor profile
Total Awards
4
Total $
$185.0M
Top Agency
Department of Health and Human Services
NAICS Count
2
Total Awards
4
Total Obligated
$185.0M
Agencies Served
1
Expiring Contracts
2
Top Agencies
| Agency | Awards | Total Obligated |
|---|---|---|
| Department of Health and Human Services | 4 | $185.0M |
Top NAICS Codes
Expiring Contracts (2)
HHSO100201600021C475 days remaining
MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP
Department of Health and Human Services|Expires Dec 31, 2027
$28.9M
HHSO100201600021C475 days remaining
MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP
Department of Health and Human Services|Expires Dec 31, 2027
$28.9M
All Awards
COST PLUS FIXED FEENO SET ASIDE USED.
THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERVENTION MBP091, AS AN IMMUNOTHERAPY FOR THE TREATMENT OF MARBURG VIRUS INFECTION.
Department of Health and Human Services75A50122C00076$110.9M
COST PLUS FIXED FEENO SET ASIDE USED.
MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP
Department of Health and Human ServicesHHSO100201600021C$28.9M
NO SET ASIDE USED.
MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP
Department of Health and Human ServicesHHSO100201600021C$28.9M
COST PLUS FIXED FEENO SET ASIDE USED.
DEVELOPMENT OF A PAN-BOTULINUM NEUROTOXIN MEDICAL COUNTERMEASURE
Department of Health and Human Services75A50120C00198$16.4M
Related insights
Spend by Year
Annual obligated spend trend